<> Glenmark Life Sciences Share Price Today: Live Glenmark Life Sciences Share Price NSE/BSE | 5paisa
GLS

Glenmark Life Sciences Share PriceGlenmark Life Sciences

₹376.3
-3.3 (-0.87%)
As on 04 February, 2023 | 07:57 BSE: 543322 NSE: GLS

Glenmark Life Sciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Glenmark Life Sciences

Start SIP

Glenmark Life Sciences Share Price

  • Over 1 Month -10.15%
  • Over 3 Month -13.4%
  • Over 6 Month -17.41%
  • Over 1 Year -34.15%

Glenmark Life Sciences Key Statistics

P/E Ratio 11
PEG Ratio 0.4
Market Cap Cr 4,611
Price to Book Ratio 2.2
EPS 34.2
Dividend 2.8
Relative Strength Index 19.42
Money Flow Index 12.8
MACD Signal -8.31
Average True Range 9.08

Glenmark Life Sciences Investment Rating

  • Master Rating:
  • Glenmark Life Sciences has an operating revenue of Rs. 2,053.96 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 27% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 77 which is a FAIR score but needs to improve its earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 140 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Glenmark Life Sciences Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 541509490514
Operating Expenses Qtr Cr 395366343372
Operating Profit Qtr Cr 145144147142
Depreciation Qtr Cr 11101010
Interest Qtr Cr 0000
Tax Qtr Cr 36373839
Net Profit Qtr Cr 10510710999

Glenmark Life Sciences Technicals

EMA & SMA

Current Price
₹376.3
-3.3 (-0.87%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 396.55
  • 50 Day
  • 408.82
  • 100 Day
  • 418.95
  • 200 Day
  • 449.95
  • 20 Day
  • 400.77
  • 50 Day
  • 415.54
  • 100 Day
  • 414.4
  • 200 Day
  • 432.82

Glenmark Life Sciences Resistance and Support

PIVOT
₹380.2
Resistance
First Resistance 382.6
Second Resistance 385.6
Third Resistance 388
RSI 19.43
MFI 12.8
MACD Single Line -8.31
MACD -10.52
Support
First Resistance 377.2
Second Resistance 374.8
Third Resistance 371.8

Glenmark Life Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 78,652 5,573,281 70.86
Week 67,218 4,721,406 70.24
1 Month 51,207 3,531,241 68.96
6 Month 118,364 7,878,279 66.56

Glenmark Life Sciences Result Highlights

Glenmark Life Sciences Synopsis

NSE-Medical-Ethical Drugs

Glenmark Life Scienc belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 2123.21 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2022. Glenmark Life Sciences Ltd. is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963.
Market Cap 4,611
Sales 2,054
Shares in Float 2.08
No of funds 23
Yield 2.79
Book Value 2.24
U/D Vol ratio 0.6
LTDebt / Equity
Alpha -0.15
Beta 0.57

Glenmark Life Sciences

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 82.85%82.85%82.85%
Mutual Funds 0.71%0.71%
Insurance Companies 0.07%0.07%
Foreign Portfolio Investors 4.45%6.04%7.58%
Financial Institutions/ Banks
Individual Investors 9.78%9.14%8.14%
Others 2.85%1.19%0.72%

Glenmark Life Sciences Management

Name Designation
Mr. Glenn Saldanha Chairman & Non-Exe.Director
Mr. Yasir Rawjee Managing Director & CEO
Mr. Sumantra Mitra Executive Director
Mr. V S Mani Non Executive Director
Mr. Sridhar Gorthi Independent Director
Mrs. Manju Agarwal Independent Director
Mr. Taruvai Laxminarayanan Easwar Independent Director
Ms. Gita Nayyar Independent Director

Glenmark Life Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Glenmark Life Sciences Corporate Action

Date Purpose Remarks
2023-01-27 Quarterly Results
2022-10-21 Quarterly Results
2022-08-04 Quarterly Results
2022-04-20 Audited Results & Final Dividend
2022-02-08 Quarterly Results
Date Purpose Remarks
2021-11-23 INTERIM Rs.10.50 per share(525%)Interim Dividend

Glenmark Life Sciences MF Shareholding

Name Amount(cr)
Quant Active Fund Growth 3480
Motilal Oswal S&P BSE Healthcare ETF 6

Glenmark Life Sciences FAQs

What is Share Price of Glenmark Life Sciences ?

Glenmark Life Sciences share price is ₹376 As on 04 February, 2023 | 07:43

What is the Market Cap of Glenmark Life Sciences ?

The Market Cap of Glenmark Life Sciences is ₹4610.7 Cr As on 04 February, 2023 | 07:43

What is the P/E ratio of Glenmark Life Sciences ?

The P/E ratio of Glenmark Life Sciences is 11 As on 04 February, 2023 | 07:43

What is the PB ratio of Glenmark Life Sciences ?

The PB ratio of Glenmark Life Sciences is 2.2 As on 04 February, 2023 | 07:43

Q2FY23